Loading...

So at the St. Jude Children's Research Hospital, for the first time, they were able to find a mid-kind and it plays a preventative role against Alzheimer's. And this protein is known to build up an Alzheimer's patient. Now research is connected with amyloid data, a protein that accumulates in the brain, and that's the hallmark of Alzheimer's. So this research was published August 21st in Nature, Structural and Electrical Biology, and the research revealed that mid-kind prevents amyloid data from clumping. As I was mentioning, I was talking about the clumping. And consequently, Alzheimer's disease models lacking mid-kind show more amyloid data accumulation. And finding the groundwork for better understanding of the disease preventing that relationship of mid-kind and subsequent drug discovery pathways. So mid-kind is a small, multi-functional growth factor protein, and it's found during embryonic development, but it's also involved in normal cell growth.